Drug Type Vaccine |
Synonyms DELTA-19 |
Target |
Mechanism SARS-CoV-2 antigen inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | US | 15 Apr 2022 | |
Influenza, Human | Preclinical | US | 15 Apr 2022 |